FibroGen, Inc. (BMV:FGEN)
205.00
-5.00 (-2.38%)
At close: Oct 9, 2025
FibroGen Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Net Income | -2.07 | -47.58 | -284.23 | -293.65 | -290.02 | -189.29 | Upgrade |
Depreciation & Amortization | 1.64 | 2.69 | 9.93 | 10.6 | 14.81 | 22.05 | Upgrade |
Stock-Based Compensation | 11.89 | 24.52 | 50.77 | 65.6 | 71.16 | 72.72 | Upgrade |
Other Adjustments | -13.52 | -10.9 | 30.72 | 2.45 | 62.41 | 1.46 | Upgrade |
Change in Receivables | -15.7 | -6.74 | 3.43 | 0.77 | 25.18 | -11.97 | Upgrade |
Changes in Inventories | 10.84 | 22.2 | -1.7 | -11 | -14.16 | -9.18 | Upgrade |
Changes in Accounts Payable | 0.8 | 14.51 | -15.51 | 5.91 | 0.81 | 17.73 | Upgrade |
Changes in Accrued Expenses | -63.99 | -91.52 | -49.79 | 90.59 | 16.31 | 30.74 | Upgrade |
Changes in Unearned Revenue | 8.74 | -28.3 | -28.17 | -4.13 | 57.64 | 45.08 | Upgrade |
Changes in Other Operating Activities | 33.22 | -15.08 | -30.48 | -13.07 | -26.36 | 102.27 | Upgrade |
Operating Cash Flow | -23.44 | -138 | -315.02 | -145.93 | -82.23 | 81.6 | Upgrade |
Capital Expenditures | -0.25 | -0.27 | -2.52 | -3.74 | -5.19 | -3.99 | Upgrade |
Sale of Property, Plant & Equipment | - | 1.05 | - | 0.01 | - | - | Upgrade |
Purchases of Intangible Assets | - | - | - | -35 | -25 | - | Upgrade |
Purchases of Investments | - | -8.63 | -251.83 | -164.02 | -484.14 | -12.09 | Upgrade |
Proceeds from Sale of Investments | - | 133.84 | 407.35 | 291.87 | 87.36 | 468.57 | Upgrade |
Other Investing Activities | - | - | 0.66 | - | - | - | Upgrade |
Investing Cash Flow | 2.45 | 125.99 | 153.66 | 89.12 | -426.97 | 452.49 | Upgrade |
Long-Term Debt Issued | - | - | 74.08 | 49.75 | - | - | Upgrade |
Long-Term Debt Repaid | -0.02 | -0.04 | -0.48 | -0.54 | -5.89 | -13.02 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -0.02 | -0.04 | 73.59 | 49.21 | -5.89 | -13.02 | Upgrade |
Issuance of Common Stock | - | 0.14 | 52.14 | 4.18 | 12.7 | 37.83 | Upgrade |
Repurchase of Common Stock | -0.17 | -0.35 | -0.24 | -5.17 | -7.37 | -11.46 | Upgrade |
Net Common Stock Issued (Repurchased) | -0.17 | -0.22 | 51.9 | -0.98 | 5.33 | 26.37 | Upgrade |
Other Financing Activities | - | - | -2.75 | -1.45 | - | - | Upgrade |
Financing Cash Flow | -0.22 | -0.26 | 122.75 | 46.78 | -0.56 | 13.34 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.75 | 0.75 | -3.4 | -5.48 | 2.6 | 4.7 | Upgrade |
Net Cash Flow | -20.87 | -11.51 | -42.01 | -15.52 | -507.17 | 552.13 | Upgrade |
Beginning Cash & Cash Equivalents | 140.71 | 113.69 | 155.7 | 171.22 | 678.39 | 126.27 | Upgrade |
Ending Cash & Cash Equivalents | 119.84 | 102.18 | 113.69 | 155.7 | 171.22 | 678.39 | Upgrade |
Free Cash Flow | -23.69 | -138.27 | -317.54 | -149.67 | -87.42 | 77.61 | Upgrade |
FCF Margin | 32.53% | -466.78% | -678.46% | -106.35% | -37.15% | 44.02% | Upgrade |
Free Cash Flow Per Share | -5.87 | -34.55 | -81.59 | -39.98 | -23.67 | 21.59 | Upgrade |
Levered Free Cash Flow | -11.1 | -143.37 | -328.87 | -169.28 | -252.06 | 2.38 | Upgrade |
Unlevered Free Cash Flow | -144.29 | -245.91 | -440.7 | -226.23 | -245.02 | 12.44 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.